Professor Michael Loebinger is a consultant respiratory physician at the Royal Brompton Hospital and Professor of Practice (Respiratory Medicine) at Imperial College. He is an expert in respiratory diseases with particular interest in respiratory infections, bronchiectasis, primary ciliary dyskinesia, cystic fibrosis, and tuberculosis.
He is actively involved in research and in 2006, he was awarded a Medical Research Council Clinical Research Training Fellowship. His research looked into the use of adult stem cells in lung disease, and gained significant media attention. His current research focuses around chronic lung infections, in particular bronchiectasis, Pseudomonas and non-tuberculosis mycobacterial infections and he has helped set up national and European research networks. He is the recipient of awards from the Royal Society of Medicine, European Respiratory Society, British Thoracic Society, British Association of Lung Research, American Thoracic Society, Medical Research Society and the British Lung Foundation. He also collaborates with Industry and is global, national and site principal investigator of multicentre international clinical trials.
Professor Loebinger helps to shape international practice and he co-chaired the National bronchiectasis guidelines and co-wrote the European bronchiectasis guidelines and National non-tuberculous mycobacteria guidelines. He chaired the British Thoracic Society Specialist Advisory Group for respiratory infections (2013-2016) and is presently secretary of the European Respiratory Society respiratory infection group.